Company: BOLT
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0000950170-25-054294
Chunk: 45

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 45
---
 | * |     |
| Nicole Onetto, M.D.(11)                                              |     |                     |   112,227 |     | * |     |
| All directors and executive officers as a group (7 persons)(12)      |     |                     | 2,333,734 |     |   | 6.1 |

* Represents beneficial ownership of less than 1%. (1) Based on a Schedule 13G/A filed with the SEC on February 14, 2024, reporting beneficial ownership as of December 31, 2023. The Schedule 13G/A provides information only as of December 31, 2023, and, consequently, the beneficial ownership of the above-mentioned reporting person may have changed between December 31, 2023 and March 31, 2025. Tang Capital Management, LLC (“Tang Capital Management”) is the general partner of Tang Capital Partners, LP (“Tang Capital Partners”), and Kevin Tang is the manager of Tang Capital Management. Tang Capital Management, Tang Capital Partners, and Kevin Tang shares voting and dispositive power over shares held by Tang Capital Management. The address for this entity is 4747 Executive Drive, Suite 210, San Diego, CA 92121.

<div align='center'>27</div>

Based on the Schedule 13G/A filed with the SEC on February 14, 2024, reporting beneficial ownership as of December 31, 2023. The Schedule 13G/A provides information only as of December 31, 2023, and, consequently, the beneficial ownership of the above-mentioned reporting person may have changed between December 31, 2023 and March 31, 2025. Consists of: (i) 1,821,483 shares of common stock held directly by Vivo Capital Fund VIII, L.P., of which Vivo Capital VIII, LLC (“Vivo GP”) is the general partner; (ii) 251,522 shares of common stock held directly by Vivo Capital Surplus Fund VIII, L.P., of which Vivo GP is the general partner; and (iii) 1,448,286 shares of common stock held directly by Vivo PANDA Fund, L.P. (“Vivo PANDA LP”), of which Vivo PANDA, LLC (“Vivo PANDA GP”) is the general partner. The voting members of Vivo GP are Michael Chang, Frank Kung, Edgar Engleman, Shan Fu, and Jack Nielsen.